Hahn RG - Search Results

1

Phase I study of difluoromethylornithine in combination with recombinant alpha 2a-interferon.

Edmonson JH, Kovach JS, Buckner JC, Kvols LK, Hahn RG. Edmonson JH, et al. Among authors: hahn rg. Cancer Res. 1988 Nov 15;48(22):6584-6. Cancer Res. 1988. PMID: 3141046

2

A phase II study of recombinant human alpha-interferon in advanced hormone-refractory prostate cancer.

van Haelst-Pisani CM, Richardson RL, Su J, Buckner JC, Hahn RG, Frytak S, Kvols LK, Burch PA. van Haelst-Pisani CM, et al. Among authors: hahn rg. Cancer. 1992 Nov 1;70(9):2310-2. doi: 10.1002/1097-0142(19921101)70:9<2310::aid-cncr2820700916>3.0.co;2-4. Cancer. 1992. PMID: 1382829 Clinical Trial.

3

Does histologic grade in soft tissue sarcoma influence response rate to systemic chemotherapy?

van Haelst-Pisani CM, Buckner JC, Reiman HM, Schaid DJ, Edmonson JH, Hahn RG. van Haelst-Pisani CM, et al. Among authors: hahn rg. Cancer. 1991 Dec 1;68(11):2354-8. doi: 10.1002/1097-0142(19911201)68:11<2354::aid-cncr2820681104>3.0.co;2-s. Cancer. 1991. PMID: 1933770

4

A phase II randomized trial of megestrol acetate or dexamethasone in the treatment of hormonally refractory advanced carcinoma of the prostate.

Patel SR, Kvols LK, Hahn RG, Windschitl H, Levitt R, Therneau T. Patel SR, et al. Among authors: hahn rg. Cancer. 1990 Aug 15;66(4):655-8. doi: 10.1002/1097-0142(19900815)66:4<655::aid-cncr2820660409>3.0.co;2-p. Cancer. 1990. PMID: 2201425 Clinical Trial.

5

Complete responses and long-term survivals after systemic chemotherapy for patients with advanced malignant melanoma.

Ahmann DL, Creagan ET, Hahn RG, Edmonson JH, Bisel HF, Schaid DJ. Ahmann DL, et al. Among authors: hahn rg. Cancer. 1989 Jan 15;63(2):224-7. doi: 10.1002/1097-0142(19890115)63:2<224::aid-cncr2820630203>3.0.co;2-i. Cancer. 1989. PMID: 2642731 Clinical Trial.

6

An evaluation of recombinant leukocyte A interferon with aspirin in patients with metastatic renal cell cancer.

Creagan ET, Buckner JC, Hahn RG, Richardson RR, Schaid DJ, Kovach JS. Creagan ET, et al. Among authors: hahn rg. Cancer. 1988 May 1;61(9):1787-91. doi: 10.1002/1097-0142(19880501)61:9<1787::aid-cncr2820610911>3.0.co;2-q. Cancer. 1988. PMID: 3162699

7

Phase II evaluation of menogaril in patients with advanced hypernephroma.

Long HJ, Hauge MD, Therneau TM, Buckner JC, Frytak S, Hahn RG. Long HJ, et al. Among authors: hahn rg. Invest New Drugs. 1991 Aug;9(3):261-2. doi: 10.1007/BF00176980. Invest New Drugs. 1991. PMID: 1838363 Clinical Trial.

8

The effect on survival of initial chemotherapy in advanced breast cancer: polychemotherapy versus single drug.

Ahmann DL, Schaid DJ, Bisel HF, Hahn RG, Edmonson JH, Ingle JN. Ahmann DL, et al. Among authors: hahn rg. J Clin Oncol. 1987 Dec;5(12):1928-32. doi: 10.1200/JCO.1987.5.12.1928. J Clin Oncol. 1987. PMID: 3316516 Clinical Trial.

9

Phase II study of maytansine and chlorozotocin in patients with disseminated malignant melanoma.

Ahmann DL, Frytak S, Kvols LK, Hahn RG, Edmonson JH, Bisel HF, Creagan ET. Ahmann DL, et al. Among authors: hahn rg. Cancer Treat Rep. 1980 Apr-May;64(4-5):721-3. Cancer Treat Rep. 1980. PMID: 6448689 No abstract available.

10

Phase II study in advanced sarcoma: randomized trial of pyrazofurin versus combination cyclophosphamide, doxorubicin, and cis-dichlorodiammineplatinum(II) (CAP).

Cormier WJ, Hahn RG, Edmonson JH, Eagan RT. Cormier WJ, et al. Among authors: hahn rg. Cancer Treat Rep. 1980 Apr-May;64(4-5):655-8. Cancer Treat Rep. 1980. PMID: 7191779 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

579 results

Search Page

Filters